Medicine:Prostatic urethral lift
Prostatic urethral lift (marketed as Urolift) is a minimally invasive procedure for the treatment of benign prostatic hyperplasia. This procedure can be done under local anesthesia in an outpatient consultation.[1]
Procedure
This procedure is done through cystoscopy and it consists on the placement of an implant that compress the lateral lobes of the prostate that cause the obstruction, dilating the prostatic urethra.[2]
Benefits
This procedure likely improves quality of life without additional negative side effects when compared with a sham surgery.[3] Compared with transurethral resection of the prostate, the standard surgery for treating benign prostatic hyperplasia, this procedure may be less effective in reducing urinary symptoms but may preserve ejaculation and have fewer unwanted effects on erections.[3]
Harms
The most common side effects include dysuria and hematuria due to the manipulation of the prostatic urethra, although it does not require routine catheterization due to its less invasive nature.[1]
References
- ↑ 1.0 1.1 Sountoulides, Petros; Karatzas, Anastasios; Gravas, Stavros (January 2019). "Current and emerging mechanical minimally invasive therapies for benign prostatic obstruction". Therapeutic Advances in Urology 11: 1756287219828971. doi:10.1177/1756287219828971. ISSN 1756-2872. PMID 30792821.
- ↑ Garcia, Cindy; Chin, Peter; Rashid, Prem; Woo, Henry H. (March 2015). "Prostatic urethral lift: A minimally invasive treatment for benign prostatic hyperplasia". Prostate International 3 (1): 1–5. doi:10.1016/j.prnil.2015.02.002. ISSN 2287-8882. PMID 26157759.
- ↑ 3.0 3.1 Jung, Jae Hung; Reddy, Balaji; McCutcheon, Karen Ann; Borofsky, Michael; Narayan, Vikram; Kim, Myung Ha; Dahm, Philipp (25 May 2019). "Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia". The Cochrane Database of Systematic Reviews 5: CD012832. doi:10.1002/14651858.CD012832.pub2. ISSN 1469-493X. PMID 31128077.
 |
